Sign In
Buy NVAX
$10.20
-0.0100 (-0.0979%)
At Close: Jun 03, 2026
COVID-19 Vaccine Maker Novavax Swings To Profit As Sales Climb
02:19pm, Thursday, 26'th Feb 2026
Novavax Inc. (NASDAQ: NVAX) shares are up on Thursday following the company's announcement of its fourth-quarter and full-year 2025 financial results.
Novavax (NVAX) Beats Q4 Earnings and Revenue Estimates
01:16pm, Thursday, 26'th Feb 2026
Novavax (NVAX) came out with quarterly earnings of $0.11 per share, beating the Zacks Consensus Estimate of a loss of $0.66 per share. This compares to a loss of $0.51 per share a year ago.
S&P 500, Nasdaq Struggle Amid AI Rotation Pain
12:05pm, Thursday, 26'th Feb 2026
While the Dow is higher, the Nasdaq and S&P 500 are struggling for gains as AI sentiment dampens
Novavax raises 2026 adjusted revenue outlook on strength in vaccine deals
08:06am, Thursday, 26'th Feb 2026
Novavax raised its adjusted revenue forecast for 2026 on Thursday, as it expects milestone payments from vaccine supply and licensing deals to offset pressure from sagging demand.
Novavax Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights
08:00am, Thursday, 26'th Feb 2026
Pfizer agreement announced in January 2026 for non-exclusive license to utilize Matrix-M® in two infectious disease areas Multiple Material Transfer Agreements signed in 2025 and Q1 2026 with pharmac
Novavax (NVAX) Upgraded to Buy: Here's What You Should Know
01:00pm, Monday, 23'rd Feb 2026
Novavax (NVAX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
What's in Store for These 5 Medical Companies This Earnings Season?
10:11am, Monday, 23'rd Feb 2026
IRWD, RXRX, NVAX, VTRS and NTLA gear up for earnings as the Medical sector posts solid sales growth despite a slight profit dip so far.
Jupiter Asset Management Ltd. Sells 779,802 Shares of Novavax, Inc. $NVAX
05:40am, Monday, 23'rd Feb 2026
Jupiter Asset Management Ltd. trimmed its position in Novavax, Inc. (NASDAQ: NVAX) by 88.6% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owne
Novavax to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
08:00am, Thursday, 19'th Feb 2026
GAITHERSBURG, Md., Feb. 19, 2026 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced it will report its fourth quarter and full year 2025 financial results and operational highlights at 8:30
Is Most-Watched Stock Novavax, Inc. (NVAX) Worth Betting on Now?
10:00am, Tuesday, 17'th Feb 2026
Recently, Zacks.com users have been paying close attention to Novavax (NVAX). This makes it worthwhile to examine what the stock has in store.
Novavax (NVAX) Rises As Market Takes a Dip: Key Facts
06:45pm, Wednesday, 11'th Feb 2026
Novavax (NVAX) reached $8.97 at the closing of the latest trading day, reflecting a +2.51% change compared to its last close.
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know
10:00am, Friday, 06'th Feb 2026
Zacks.com users have recently been watching Novavax (NVAX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Why Novavax (NVAX) Dipped More Than Broader Market Today
06:46pm, Tuesday, 03'rd Feb 2026
Novavax (NVAX) concluded the recent trading session at $8.37, signifying a -3.68% move from its prior day's close.
Moderna Vs. Novavax: 2 Pandemic Vaccine Pioneers - Which Offers Better Value Today?
10:09am, Friday, 30'th Jan 2026
Moderna, Inc. and Novavax, Inc. have transitioned from pandemic-era highs to focusing on cost reduction, pipeline development, and a path to breakeven by 2028. NVAX leverages partnerships with Sanofi
This Beaten-Down Biotech Is Showing Signs of Life. Is It a Buy?
08:30am, Thursday, 29'th Jan 2026
The business may not be as strong as its performance this year suggests.
